Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Lactocepin secreted by Lactobacillus exerts anti-inflammatory effects by selectively degrading proinflammatory chemokines.

von Schillde MA, Hörmannsperger G, Weiher M, Alpert CA, Hahne H, Bäuerl C, van Huynegem K, Steidler L, Hrncir T, Pérez-Martínez G, Kuster B, Haller D.

Cell Host Microbe. 2012 Apr 19;11(4):387-96. doi: 10.1016/j.chom.2012.02.006.

2.

Posttranslational inhibition of proinflammatory chemokine secretion in intestinal epithelial cells: implications for specific IBD indications.

Hörmannsperger G, Clavel T, Hoffmann M, Reiff C, Kelly D, Loh G, Blaut M, Hölzlwimmer G, Haller D.

J Clin Gastroenterol. 2010 Sep;44 Suppl 1:S10-5. doi: 10.1097/MCG.0b013e3181e102c1.

PMID:
20562631
3.

Lactocepin as a protective microbial structure in the context of IBD.

Hörmannsperger G, von Schillde MA, Haller D.

Gut Microbes. 2013 Mar-Apr;4(2):152-7. doi: 10.4161/gmic.23444. Epub 2013 Jan 18. Review.

4.

Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation.

Hoermannsperger G, Clavel T, Hoffmann M, Reiff C, Kelly D, Loh G, Blaut M, Hölzlwimmer G, Laschinger M, Haller D.

PLoS One. 2009;4(2):e4365. doi: 10.1371/journal.pone.0004365. Epub 2009 Feb 6. Erratum in: PLoS One. 2009;4(6). doi: 10.1371/annotation/583d95a8-c18c-4c66-92be-1b1505802d86. Hörmannsperger, Gabriele [corrected to Hoermannsperger, Gabriele].

5.

A component of polysaccharide peptidoglycan complex on Lactobacillus induced an improvement of murine model of inflammatory bowel disease and colitis-associated cancer.

Matsumoto S, Hara T, Nagaoka M, Mike A, Mitsuyama K, Sako T, Yamamoto M, Kado S, Takada T.

Immunology. 2009 Sep;128(1 Suppl):e170-80. doi: 10.1111/j.1365-2567.2008.02942.x. Epub 2008 Oct 15.

6.

Lactobacillus casei secreting alpha-MSH induces the therapeutic effect on DSS-induced acute colitis in Balb/c Mice.

Yoon SW, Lee CH, Kim JY, Kim JY, Sung MH, Poo H.

J Microbiol Biotechnol. 2008 Dec;18(12):1975-83.

7.

Lactobacillus paracasei reduces intestinal inflammation in adoptive transfer mouse model of experimental colitis.

Oliveira M, Bosco N, Perruisseau G, Nicolas J, Segura-Roggero I, Duboux S, Briand M, Blum S, Benyacoub J.

Clin Dev Immunol. 2011;2011:807483. doi: 10.1155/2011/807483. Epub 2011 Jul 25.

8.

CD4+ T cells and Lactobacillus casei control relapsing colitis mediated by CD8+ T cells.

Hacini-Rachinel F, Nancey S, Boschetti G, Sardi F, Doucet-Ladevèze R, Durand PY, Flourié B, Kaiserlian D.

J Immunol. 2009 Nov 1;183(9):5477-86. doi: 10.4049/jimmunol.0804267.

9.

A comparative study of the preventative effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus acidophilus, in the TNBS model of rat colitis.

Peran L, Camuesco D, Comalada M, Bailon E, Henriksson A, Xaus J, Zarzuelo A, Galvez J.

J Appl Microbiol. 2007 Oct;103(4):836-44.

10.

Lactobacillus casei prevents the development of dextran sulphate sodium-induced colitis in Toll-like receptor 4 mutant mice.

Chung YW, Choi JH, Oh TY, Eun CS, Han DS.

Clin Exp Immunol. 2008 Jan;151(1):182-9. Epub 2007 Nov 15.

11.

Treatment with Bifidobacterium bifidum 17 partially protects mice from Th1-driven inflammation in a chemically induced model of colitis.

Philippe D, Heupel E, Blum-Sperisen S, Riedel CU.

Int J Food Microbiol. 2011 Sep 1;149(1):45-9. doi: 10.1016/j.ijfoodmicro.2010.12.020. Epub 2010 Dec 31.

PMID:
21257218
12.

Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide.

Macho Fernandez E, Valenti V, Rockel C, Hermann C, Pot B, Boneca IG, Grangette C.

Gut. 2011 Aug;60(8):1050-9. doi: 10.1136/gut.2010.232918. Epub 2011 Apr 6. Erratum in: Gut. 2011 Oct;60(10):1444. Fernandez, Elise Macho [corrected to Macho Fernandez, Elise].

PMID:
21471573
13.

Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice.

Watterlot L, Rochat T, Sokol H, Cherbuy C, Bouloufa I, Lefèvre F, Gratadoux JJ, Honvo-Hueto E, Chilmonczyk S, Blugeon S, Corthier G, Langella P, Bermúdez-Humarán LG.

Int J Food Microbiol. 2010 Nov 15;144(1):35-41. doi: 10.1016/j.ijfoodmicro.2010.03.037. Epub 2010 Apr 2.

PMID:
20452077
14.

Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model.

Daniel C, Poiret S, Goudercourt D, Dennin V, Leyer G, Pot B.

Appl Environ Microbiol. 2006 Sep;72(9):5799-805.

15.

On the benefit of whey-cultured Lactobacillus casei in murine colitis.

Ghasemi-Niri SF, Abdolghaffari AH, Fallah-Benakohal S, Hosseinpour-Feizi M, Mahdaviani P, Jamalifar H, Baeeri M, Dehghan G, Abdollahi M.

J Physiol Pharmacol. 2011 Jun;62(3):341-6.

16.

Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis.

Carroll IM, Andrus JM, Bruno-Bárcena JM, Klaenhammer TR, Hassan HM, Threadgill DS.

Am J Physiol Gastrointest Liver Physiol. 2007 Oct;293(4):G729-38. Epub 2007 Jul 19.

17.

Lactobacillus plantarum prevents the upregulation of adhesion molecule expression in an experimental colitis model.

Chu ZX, Chen HQ, Ma YL, Zhou YK, Zhang M, Zhang P, Qin HL.

Dig Dis Sci. 2010 Sep;55(9):2505-13. doi: 10.1007/s10620-009-1063-2. Epub 2009 Dec 4.

PMID:
19960256
18.

Effects of Lactobacillus salivarius 433118 on intestinal inflammation, immunity status and in vitro colon function in two mouse models of inflammatory bowel disease.

Feighery LM, Smith P, O'Mahony L, Fallon PG, Brayden DJ.

Dig Dis Sci. 2008 Sep;53(9):2495-506. Epub 2007 Dec 20.

PMID:
18157694
19.

Protective effects of Lactobacillus rhamnosus [corrected] and Bifidobacterium infantis in murine models for colitis do not involve the vagus nerve.

van der Kleij H, O'Mahony C, Shanahan F, O'Mahony L, Bienenstock J.

Am J Physiol Regul Integr Comp Physiol. 2008 Oct;295(4):R1131-7. doi: 10.1152/ajpregu.90434.2008. Epub 2008 Jul 30. Erratum in: Am J Physiol Regul Integr Comp Physiol. 2011 Jun;300(6):R1596.

20.

Therapeutic potential of two probiotics in inflammatory bowel disease as observed in the trinitrobenzene sulfonic acid model of colitis.

Amit-Romach E, Uni Z, Reifen R.

Dis Colon Rectum. 2008 Dec;51(12):1828-36. doi: 10.1007/s10350-008-9394-1. Epub 2008 Jul 17.

PMID:
18633675
Items per page

Supplemental Content

Write to the Help Desk